Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 744
Ph III recruiting: 79
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.1%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05570994	177Lu-HTK03170 in mCRPC With PSMA Positive Disease	enrolling by invitation	Phase 1 / Phase 2	50	British Columbia Cancer AgencyOTHER	1	Jan 8, 2026	clinicaltrials
NCT03459820	Prostate Cancer Patient Management With 18F-DCFPyL PET/CT	enrolling by invitation	Phase 2 / Phase 3	1,500	Sir Mortimer B. Davis - Jewish General HospitalOTHER	1	Nov 27, 2023	clinicaltrials